Food and Drug Administration
Federal health advisers are recommending that a decades-old birth control pill be sold without a prescription.
The vaccine is the first to prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV) for adults 60 and older.
The 5th U.S. Circuit Court of Appeals in New Orleans ruled Wednesday that the Food and Drug Administration’s initial approval of mifepristone in 2000 should remain in effect.
The pharma-bashing Biden administration is now joining drugmakers raising alarm about courts second-guessing the Food and Drug Administration.
WHAT'S HAPPENING
Never has a court overruled the FDA’s approval of a drug, much less a drug that has been on the market for over 20 years.
Hundreds of industry leaders voiced support for the FDA after a judge ruled to invalidate the drug mifepristone's approval by the agency.
The ruling from a Texas judge will go into effect in seven days, giving time for the Biden administration to appeal.
The lifesaving nasal spray is expected to hit store shelves and online U.S. retailers by late summer -- though it's not clear how much it will cost.
People may be able to purchase the treatment at their pharmacy — a change experts are celebrating.
The announcement follows a surge in COVID-19, flu and respiratory syncytial virus (RSV) towards the end of 2022, igniting fears of a “tripledemic.”